Stay updated on Topical BMX-010 in Skin Diseases Clinical Trial

Sign up to get notified when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Topical BMX-010 in Skin Diseases Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a consolidated Locations section listing California, Colorado, Florida, Indiana, New York, South Carolina, Tennessee, and Texas, and removed the separate state-location entries. The page revision was updated to v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T10:18:56.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and v3.2.0 was removed in the page revision history, with no substantive changes to the study details, eligibility criteria, outcomes, or locations.
    Difference
    0.1%
    Check dated 2025-11-24T17:03:12.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The notice about a lapse in government funding and potential delays in updates has been removed from the page.
    Difference
    0.4%
    Check dated 2025-11-17T15:03:44.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    No significant changes detected in core study content, only formatting/UI updates. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:31:45.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.
    Difference
    5%
    Check dated 2025-10-05T13:30:50.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Page now shows Revision: v3.1.0 and removes several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) from the content; core page content appears to be re-scoped rather than expanded.
    Difference
    0.6%
    Check dated 2025-09-28T09:39:27.000Z thumbnail image

Stay in the know with updates to Topical BMX-010 in Skin Diseases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Topical BMX-010 in Skin Diseases Clinical Trial page.